Investing.com - Edwards Lifesciences (NYSE:EW) reported second quarter earnings that beat analysts' expectations on Thursday and revenue that topped forecasts.
The firm reported earnings per share of $0.34 on revenue of $925M. Analysts polled by Investing.com expected EPS of $0.18 on revenue of $790.05M. .
Edwards Lifesciences shares gained 3.40% to trade at $80.01 in after-hours trade following the report.
For the year, Edwards Lifesciences shares are down 0.49%, under-performing the S&P 500 which is up 0.16% year to date.
Edwards Lifesciences follows other major Healthcare sector earnings this month
On Thursday, July 16, 2020, J&J reported second quarter EPS of $1.67 on revenue of $18.34B, compared to forecasts of EPS of $1.49 on revenue of $17.61B.
Novartis ADR earnings beat analyst's expectations on Tuesday, with second quarter EPS of $1.36 on revenue of $11.35B. Investing.com analysts expected EPS of $1.34 on revenue of $11.9B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar